drugset / Trial / NCT02730481
A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies
NaSingle-groupOpen-labelTreatment
Summary
This is a multicenter, open-label, safety study. Eligible subjects will be adults with advanced malignancies. The study includes a pretreatment and treatment phase. The pretreatment phase consists of screening and baseline periods. The treatment phase consists of 4-week treatment periods and a follow-up period.
Timeline
- Start
- 2016-03
- Primary completion
- 2021-03
- Completion
- 2021-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HM30181AK-US | Unknown | 15 mg | — |
| Subject | Paclitaxel | Small molecule | 30 mg | — |